e-learning
resources
Munich 2006
Tuesday 05.09.2006
Bronchiolitis in infancy, treatment and outcome
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Recombinant human deoxyribonuclease treatment in hospital management of infants with moderate-severe bronchiolitis
E. Corazzesi, R. Nenna, V. Tromba, R. Tuccinardi, S. Piacenti, F. Scalercio, E. Trapasso, S. Brenna, C. Moretti, F. Midulla (Rome, Italy)
Source:
Annual Congress 2006 - Bronchiolitis in infancy, treatment and outcome
Session:
Bronchiolitis in infancy, treatment and outcome
Session type:
Oral Presentation
Number:
4367
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
E. Corazzesi, R. Nenna, V. Tromba, R. Tuccinardi, S. Piacenti, F. Scalercio, E. Trapasso, S. Brenna, C. Moretti, F. Midulla (Rome, Italy). Recombinant human deoxyribonuclease treatment in hospital management of infants with moderate-severe bronchiolitis. Eur Respir J 2006; 28: Suppl. 50, 4367
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Related content which might interest you:
Antibiotics in hospitalised infants with acute bronchiolitis. Is there enough evidence for prescribing?
Source: Eur Respir J 2005; 26: Suppl. 49, 28s
Year: 2005
Prevalence of rhinovirus infection in hospitalized young infants with acute bronchiolitis from a developing country
Source: Annual Congress 2003 - New perspectives in bronchiolitis
Year: 2003
Association of nasopharyngeal microbiota profiles with bronchiolitis severity in infants hospitalised for bronchiolitis
Source: Eur Respir J 2016; 48: 1329-1339
Year: 2016
The length of hospitalization in pediatric patients with bronchiolitis
Source: Annual Congress 2009 - Diagnosis and treatment of viral respiratory infections in early childhood
Year: 2009
Recombinant human DNase and lung mechanics in postoperative pediatric intensive care respirator therapy
Source: Eur Respir J 2003; 22: Suppl. 45, 129s
Year: 2003
Management of severe asthma in children
Source: International Congress 2018 – ME11 Management of severe asthma in children FULLY BOOKED
Year: 2018
ME11 Management of severe asthma in children
Source: Paris 2018 - Educational material
Year: 2018
Management of severe asthma in children
Source: Virtual Congress 2020 – Reducing the burden of asthma
Year: 2020
Management of severe asthma in children
Source: Annual Congress 2010 - ERS/[italic]Lancet[/italic] Asthma
Year: 2010
Acute bronchiolitis in hospitalised patients: inappropriate use of corticosteroids
Source: Eur Respir J 2005; 26: Suppl. 49, 29s
Year: 2005
Is RSV positive testing predictive of a more severe course of disease in patients with acute bronchiolitis admitted to hospital?
Source: Eur Respir J 2005; 26: Suppl. 49, 627s
Year: 2005
Human metapneumovirus involved in acute exacerbations in COPD patients?
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011
DNase treatment for atelectasis in infants with severe respiratory syncytial virus bronchiolitis
Source: Eur Respir J 2001; 18: 734-737
Year: 2001
Characterization of patients with pneumonia and chronic structural lung disease admitted to an ICU
Source: International Congress 2019 – COPD and other specific entities in intensive care unit medicine
Year: 2019
Severe RSV bronchiolitis in children
Source: Virtual Congress 2020 – Respiratory viruses in the "pre COVID-19" era
Year: 2020
The efficacy of multiple use of interferon-gamma inducer in treatment of recurrent acute respiratory viral infections in children with bronchial asthma
Source: Annual Congress 2013 –Preschool wheeze
Year: 2013
Costs of the patients hospitalized with acute exacerbations of chronic obstructive pulmonary disease in a tertiary university hospital of Turkey
Source: International Congress 2015 – COPD: chronic disease and comorbidities
Year: 2015
A comparison of in-hospital and HITH-based treatment of respiratory exacerbations in children with bronchiectasis
Source: International Congress 2019 – Novel findings in paediatric respiratory infections
Year: 2019
Severe outcomes of COVID-19 among patients with COPD and asthma
Source: ERJ Open Res, 7 (1) 00594-2020; 10.1183/23120541.00594-2020
Year: 2021
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept